New Findings on Fatty Liver Disease Described by Investigators at Cornell University (A Retinoic Acid Receptor Beta 2 Agonist Attenuates Transcriptome and Metabolome Changes Underlying Nonalcohol-associated Fatty Liver Disease)

Source :: Obesity, Fitness & Wellness Week. March 5, 2022, 3633
Publication Year :: 2022
Abstract: 2022 MAR 5 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Liver Diseases and Conditions - Fatty Liver Disease are [...]

Subjects :: Agonists (Biochemistry) -- Research
Tretinoin -- Health aspects
Fatty liver -- Care and treatment -- Genetic aspects -- Development and progression
Pharmacology, Experimental
Genetic transcription -- Research
Lipid metabolism -- Research
Health

Tools